Trevi Therapeutics (TRVI) Announces Proposed $100M Share Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street closes lower as oil prices jump, indexes notch monthly gains
- The Warsh pivot markets didn't expect
- Oil settles up by more than 2.5% as US and Iran resume military attacks
- Energy stocks rally as fresh U.S.-Iran attacks drive oil prices higher
- BofA turns S&P 500 signals from red to yellow: What to buy now
Trevi Therapeutics (TRVI) PT Raised to $23 at Oppenheimer
June 2, 2025 4:03 PM EDTOppenheimer analyst Leland Gershall raised the price target on Trevi Therapeutics (NASDAQ: TRVI) to $23.00 (from $20.00) while maintaining a Outperform rating.
The analyst comments "Further detail to this morning's positive topline Phase 2b announcement per the company's webcast with KOL and slides... More
